Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis

American Journal of Kidney Diseases

Volumn 28, Issue 2, 1996, Pages 186-194

  Göbel, Ursula ^b   Eichhorn, Jens ^b   Kettritz, Ralph ^b   Briedigkeit, Lutz ^b   Sima, Dagmar ^b   Lindschau, Carsten ^b   Haller, Hermann ^b   Luft, Friedrich C ^a  

^a FRANZ VOLHARD CLINIC   (Germany)

^b NONE

Author keywords

Antiendothelial cell autoantibodies; antineutrophil cytoplasmic antibodies; disease activity; Wegener's granulomatosis

Indexed keywords

AUTOANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANIMAL CELL; ANTIBODY DETECTION; ARTERIOSCLEROSIS; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; PROGNOSIS; RECURRENCE RISK; REMISSION; WEGENER GRANULOMATOSIS;

EID: 0029821380     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90300-5     Document Type: Article

References (32)

1. Jaffe EA, Nachman RL, Becker CG, Minicki CR: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2748-2754, 1973
2. Cines DB, Lyss AP, Reeber M, Bina M, DeHoratius RJ: Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 73:611-625, 1984
3. Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS: Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells. J Clin Invest 77:1428-1435, 1986
4. Leung DYM, Moake JL, Havens PL, Kim M, Pober JS: Lytic antiendothelial cell antibodies in hemolytic uremic syndrome. Lancet 2:183-186, 1988
5. Holt CM, Lindsey N, Moult J: Antibody-dependent cellular cytotoxicity of vascular endothelium: Characterisation and pathogenic associations in systemic sclerosis. Clin Exp Immunol 78:358-363, 1989
6. Cervera R, Ramirez G, Grau JM, Asherson RA, Khamashta MA, Urbano-Marzez A, Hughes GRV: Antibodies to endothelial cells in dermatomyositis: Association to interstitial lung disease. BMJ 302:880-881, 1991
7. Cines DB, Tomaski A, Tannebaum S: Immune endothelial cell injury in heparin-associated thrombocytopenia. N Engl J Med 316:581-584, 1987
8. Miltenberg AMM, Meijer-Paape JJ, Weenging MR, Daha MR, van Es LA, Van der Woude FJ: Induction of antibody-dependent cellular cytotoxicity against endothelial cells by renal transplantation. Transplantation 48:681-688, 1989
9. Brasile L, Kremer JM, Clarke JL, Cerilli J: Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am J Med 87:74-79, 1989
10. Ferraro G, Meroni PL, Tincani A, Sinico A, Barcellini W, Radice A, Gregorini G, Froldi M, Borghi MO, Balestrieri G: Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol 79:47-51, 1991
11. Savage COS, Pottinger BE, Gaskin G: Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: Presence of anti-endothelial cell antibodies and their relationship to anti-neutrophil antibodies. Clin Exp Immunol 85:14-19, 1991
12. Frampton G, Jayne DRW, Perry GJ, Lockwood CM, Cameron JS: Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol 82:227-232, 1990
13. Frampton G, Chan D, Khouri N, Cameron JS: Pathogenetic aspects of autoantibodies to endothelial cells in systemic vasculitis, in Gross WL (ed): ANCA-Associated Vasculitides: Immunological and Clinical Aspects. New York, NY, Plenum, 1993, pp 35-44
14. Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, van der Giessen M, van der Hem GK, The TH: Autoantibodies against neutrophils and monocytes: Tools for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1:425-429, 1985
15. Pettersson E, Heigl Z: Antineutrophil cytoplasmic antibody (cANCA and pANCA) titers in relation to disease activity in patients with necrotizing vasculitis: A longitudinal study. Clin Nephrol 37:219-228, 1992
16. Kerr GS, Fleisher TA, Hallahan CW, Leavitt RY, Fauci AS, Hoffman GS: Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. Arthritis Rheum 36:365-371, 1993
17. Fauci A, Haynes B, Katz P, Wolff S: Wegener's granulomatosis: Prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76-85, 1983
18. Sima D, Hiepe F, Schössler W: Nachweis von zirkulierenden Anti-Endothelzell-Antikörpern bei Autoimmunkrankheiten mittels Enzymimmunoassay. Dermatol Monatsschrift 177:117-120, 1991
19. Jennette JC, Falk RJ: Disease associations and pathogenic role of antineutrophil cytoplasmic autoantibodies in vasculitis. Curr Opin Rheum 4:9-15, 1992
20. Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, van der Giessen M, van der Hem GK, The TH: Association between active Wegener's granulomatosis and anticytoplasmic antibodies. Arch Intern Med 149:2461-2465, 1989
21. Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CCM: Prevention of relapses of Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 336:709-711, 1991
22. Jayne D, Heaton A, Brownlee A, Evans DB, Lockwood CM: Sequential antineutrophil cytoplasm antibody titres in the management of systemic vasculitis. Nephrol Dial Transplant 5:309-310, 1990
23. Nölle B, Specks U, Lüdemann J, Rohrbach MS, De-Remee RA, Gross WL: Anticytoplasmic antibodies: Their immunodiagnostic value in Wegener's granulomatosis. Ann Intern Med 111:28-40, 1989
24. Rao JK, Weinberger M, Oddone EZ, Allen NB, Landsman P, Feussner JR: The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. Ann Intern Med 123:925-932, 1995
25. Rao JK, Allen NB, Feussner JR, Weinberger M: A prospective study of antineutrophil cytoplasmic antibody (c-ANCA) and clinical criteria in diagnosing Wegener's granulomatosis. Lancet 346:926-931, 1995
26. Perry GJ, Elston T, Khouri NA, Chan TM, Cameron JS, Frampton G: Antiendothelial cell antibodies in lupus: Correlations with renal injury and circulating markers of endothelial damage. Q J Med 86:727-734, 1993
27. Meroni PL, Papa ND, Sinicio A: Antiendothelial cell antibodies in primary vasculitides. Contrib Nephrol 94:89-97, 1991
28. Van der Zee JM, Miltenburg AM, Siegert CE, Daha MR, Breedveld FC: Antiendothelial cell antibodies in systemic lupus erythematosus: Enhanced antibody binding to interleukin-1-stimulated endothelium. Int Arch Allergy Appl Immunol 104:131-135, 1994
29. Haller H, Eichhorn J, Pieper K, Göbel U, Luft FC: Leukocyte integrin expression in Wegener's granulomatosis. J Am Soc Nephrol 7:40-48, 1996
30. Schmitt WH, Heesen C, Csernok E, Rautmann A, Gross WL: Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Arthritis Rheum 35:1088-1096, 1992
31. Wangel AG, Temonen M, Brummer-Korvenkontio M, Vaheri A: Antiendothelial cell antibodies in nephropathia epidemica and other viral disease. Clin Exp Immunol 90:13-17, 1992
32. Mayet W-J, Csernok E, Symkowiak C, Gross WL, Meyer zum Büschenfeld K-H: Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 82:1221-1229, 1993